Isaacs, GB
Daniel Isaacs, Elstree GB
Patent application number | Description | Published |
---|---|---|
20130171079 | COMPOSITION TO STABILISE KOJIC ACID - A novel composition is disclosed to provide stable kojic acid in a cosmetically or pharmaceutically acceptable medium using a synergistic combination of a sulphur dioxide releasing agent such as sodium metabisulphite and one or more catalases, catalase mimetics, superoxide dismutases, and superoxide dismutase mimetics. | 07-04-2013 |
David Isaacs, West Hampstead GB
Patent application number | Description | Published |
---|---|---|
20100291695 | DETECTION OF NUCLEIC ACID SEQUENCE MODIFICATION - The invention relates to a non-PCR based method for the detection of a nucleotide modification in a nucleic acid sample comprising contacting a solution comprising nucleic acid sample with a nucleic acid probe in a temperature-controlled and UV illuminated container and measuring the UV absorption of the nucleic acid sample/nucleic acid probe complex. | 11-18-2010 |
David Isaacs, London GB
Patent application number | Description | Published |
---|---|---|
20100010749 | SEQUENCING - The invention relates to improvements in sequencing of polymers. In particular, the invention relates to a method of sequencing a polymer, the method comprising providing a plurality of data sets, each set comprising data representing the concentration of synthesised polymers from a plurality of chain termination reactions, wherein the data sets include termination artefacts; aligning two or more of the data sets based on at least one termination artefact present in said two or more data sets; and determining the polymer sequence based on the aligned data. | 01-14-2010 |
Elliot Isaacs, Elstree GB
Patent application number | Description | Published |
---|---|---|
20130171079 | COMPOSITION TO STABILISE KOJIC ACID - A novel composition is disclosed to provide stable kojic acid in a cosmetically or pharmaceutically acceptable medium using a synergistic combination of a sulphur dioxide releasing agent such as sodium metabisulphite and one or more catalases, catalase mimetics, superoxide dismutases, and superoxide dismutase mimetics. | 07-04-2013 |
Elliot Isaacs, London GB
Patent application number | Description | Published |
---|---|---|
20110040236 | MICRONEEDLE ROLLER - The invention provides a microneedle roller comprising a rotatable drum, the drum including a plurality of radially projecting microneedles, wherein the microneedles are provided in substantially linear arrays, each array being carried by a support, and each array being arranged in a substantially axial direction relative to the drum. | 02-17-2011 |
20110089268 | HAIR BUILDING SOLIDS DISPENSER - The invention provides a hair building solids dispenser for storing and dispensing hair building solids comprising first electrostatic charge controller adapted for altering and/or maintaining an electrostatic charge on a surface of at least some of said solids contained within, and/or as dispensed from, said dispenser, wherein at least a substantial portion of the exterior surface of the dispenser comprises substantially electrically non-conductive material, the first electrostatic charge controller being an electrically conductive material for providing an electrical connection between the inside and outside of the dispenser. | 04-21-2011 |
20110126849 | HAIR BUILDING SOLID - A hair building solid comprising a coating, wherein the coating facilitates the formation of a dipolar electrostatic charge on the surface of the coated solid. | 06-02-2011 |
20110195039 | HAIR BUILDING SOLID AGENT - A method of treating hair comprising applying a hair building solid agent for use on or with one or more of hair, skin and hair building solids for altering and/or maintaining the electrostatic charge of the hair and/or skin such that it has a substantially negative polarity. The method further comprises applying hair building solids to hair before and/or during and/or after applying the hair building solid agent. The hair building solid agent is applied as a spray on to the hair and/or skin and/or hair building solid. | 08-11-2011 |
20120003300 | Composition Comprising Vascular Endothelial Growth Factor (VEGF) for the Treatment of Hair Loss - A composition to treat hair loss and enhance hair growth and condition. The composition comprises: i) one or more of VEGF, a VEGF biomimetic peptide, and/or a VEGFR2 receptor agonist; ii) ciclopirox olamine; and iii) a pharmaceutically acceptable carrier. | 01-05-2012 |
20120116295 | Topical Growth Factor Application Utilising a Microneedle Array - The present invention relates to improved topical administration of one or more growth factors for non-surgical, cosmetic use. In particular, a combination of one or more growth factors with a microneedle roller. Specifically, the invention resides in a kit for cosmetic use comprising: one or more growth factors, growth factor mimetics, and/or growth factor receptor agonists formulated for topical application; and means to perform wounding of skin, such as a microneedle array, wherein the wounding is targeted to at least the epidermis and/or dermis of the skin to release endogenous thrombin into dermal and/or epidermal tissue. | 05-10-2012 |
Elliot James Isaacs, London GB
Patent application number | Description | Published |
---|---|---|
20090274677 | ANTIOXIDANT FOR USE IN COSMETIC, MEDICATED AND PHARMACEUTICAL PREPARATIONS - The invention provides the use a 2,2-dimethyl chroman as a SOD mimetic in a cosmetic preparation. Cosmetic preparations comprising a 2,2-dimethyl chroman as a SOD mimetic are described, as well as methods for treating or preventing free radical damage to skin cells and treating or preventing hair loss which comprise topical administration of a 2,2-dimethyl chroman as a SOD mimetic. | 11-05-2009 |
John D. Isaacs, Newcastle Upon Tyne GB
Patent application number | Description | Published |
---|---|---|
20130345086 | CD4+ T-CELL GENE SIGNATURE FOR RHEUMATOID ARTHRITIS (RA) - The present invention relates to methods and products for the identification and diagnosis of Rheumatoid arthritis (RA), in particular for the diagnosis of anti-citrullinated peptide antibody (ACPA)-negative RA. Most particularly the invention relates to a gene expression signature comprising at least 12 biomarkers for use in the prognosis or diagnosis of RA. | 12-26-2013 |
Joy Isaacs, London GB
Patent application number | Description | Published |
---|---|---|
20140356436 | DERMOCOSMETIC COMPOSITIONS BASED ON A SYNERGISTIC COMBINATION OF COLLOIDAL SILVER AND DEOXYRIBONUCLEIC ACID - The present invention relates to dermocosmetic compositions containing, as active ingredients, a synergistic combination of colloidal silver and deoxyribonucleic acid, characterized in that the colloidal silver is more particularly an aqueous solution of electro colloidal silver. | 12-04-2014 |
Kenneth Isaacs, Wiltshire GB
Patent application number | Description | Published |
---|---|---|
20090197537 | Enhancing voice communication between a group of users in a network - Voice communication is enhanced between a group of users in a network by providing data for transmission to the group of users; adding to the data other information relating to a new active user; and transmitting the combined data and information in a single message to all other users in the group. | 08-06-2009 |
20090219871 | Method of Operation in a Dual Carrier Communication System - A mobile device in a dual carrier communication system communicates with a network via first and second carriers by receiving data in the first cell via one of the first and second carriers on one carrier frequency, whilst receiving system information and/or downlink data from a second cell via the other of the first and second carriers on another carrier frequency. | 09-03-2009 |
Rebecca Isaacs, Cambridge GB
Patent application number | Description | Published |
---|---|---|
20090210519 | EFFICIENT AND TRANSPARENT REMOTE WAKEUP - Systems and methods that facilitate remote wake up are described that provide for efficient and transparent wake up of target hosts by remote hosts. In various embodiments, a separate address can be used by a target host for wake up network traffic, which is different from a regular address associated with a target host for normal network communications. In addition, the disclosed subject matter facilitates controlling wake up operations according to trust, identity, and/or a wake up policy. | 08-20-2009 |
20090210929 | INTER-PROCESS NETWORKING FOR MANY-CORE OPERATING SYSTEMS - Systems and methods that facilitate inter-process networking are described that can provide inter-process communication, firewall restrictions, process and host mobility, as well as parallelization of task performance. In various embodiments, a computer process can be provided with its own internet protocol address and network stack to facilitate inter-process networking. In further embodiments, a gateway process can facilitate process mobility, host mobility, and parallelization of task performance, as well as management of a host area network by facilitating inter-process communication between suitably configured processes. | 08-20-2009 |